GDNF and Parkinson disease: GDNF-enriched EVs treated with transgenic Parkin Q311 (X) Intranasal injection of a mouse enhanced neuronal survival, decreased neuroinflammation, and improved motor performance in the Parkinson’s disease animal model [261].